BAYRY: Analysis & Opinions

  1. Actavis Challenges Patents - Analyst Blog

    June 10, 2013
    Actavis is looking to launch its generic versions of Diprivan and Safyral.
  2. Positive Data on Bayer/REGN's Eye Drug - Analyst Blog

    June 07, 2013
    Bayer announced positive top-line results from the phase III MYRROR study on VEGF Trap-Eye.
  3. Shire's 4Q EPS In Line, Revs Beat - Analyst Blog

    February 15, 2013
    Shire's (SHPG) fourth quarter 2012 earnings (excluding special items) of $1.58 per American Depositary Share (ADS) ...
  4. Priority Review for Bayer's Drug - Analyst Blog

    February 14, 2013
    The HealthCare unit of Bayer AG (BAYRY) recently announced that the US Food and Drug Administration (FDA) granted ...
  5. Bristol-Myers Inks OTC Deal - Analyst Blog

    February 13, 2013
    Bristol-Myers Squibb Company (BMY) recently announced that it has inked a deal with UK-based company Reckitt ...
  6. Roche Collaborates with RQx Pharma - Analyst Blog

    February 13, 2013
    Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
  7. Data on AVEO/ALPMY's Tivozanib - Analyst Blog

    February 13, 2013
    AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma, Inc. (ALPMY) recently announced final overall survival (OS) ...
  8. Sigma-Aldrich Retained at Neutral - Analyst Blog

    February 13, 2013
    We are retaining our Neutral recommendation on global lab chemical and life sciences company Sigma-Aldrich ...
  9. Shire Settles Lawsuit with Impax - Analyst Blog

    February 13, 2013
    Shire plc (SHPG) recently settled its pending litigation with Impax Laboratories, Inc. (IPXL). The litigation is ...
  10. Bayer Seeks Riociguat Approval - Analyst Blog

    February 12, 2013
    Bayer (BAYRY) recently submitted applications to the US and the EU authorities for the approval of riociguat. Bayer ...
  11. Teva Enrolls First Patient in Study - Analyst Blog

    February 12, 2013
    Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that it has enrolled the first patient in the phase IV ...
  12. Pipeline Progresses at Shire - Analyst Blog

    February 12, 2013
    Shire plc (SHPG) recently announced that the company has initiated a phase III study to evaluate the efficacy and ...
  13. Acorda Presents Encouraging Data - Analyst Blog

    February 11, 2013
    Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
  14. Pipeline Advances at Glaxo - Analyst Blog

    February 11, 2013
    Recently, GlaxoSmithKline (GSK) announced that it has submitted a regulatory application for its oncology candidate, ...
  15. Novo Nordisk Suffers Setback - Analyst Blog

    February 11, 2013
    Novo Nordisk (NVO) recently faced a setback when the US Food and Drug Administration (FDA) declined to approve its ...
  16. MDCO-BMY Deal Comes into Effect - Analyst Blog

    February 11, 2013
    The Medicines Company (MDCO) recently announced that its two-year global collaboration agreement for Recothrom with ...
  17. Glaxo Strengthens Indian Presence - Analyst Blog

    February 06, 2013
    GlaxoSmithKline (GSK) recently increased its holding in its consumer healthcare subsidiary in India, GlaxoSmithKline ...
  18. Bayer, J&J Collaborate with Portola - Analyst Blog

    February 06, 2013
    Bayer's (BAYRY) Healthcare unit and Johnson & Johnson's (JNJ) Janssen Pharmaceuticals recently collaborated with ...
  19. Bayer Presents Positive ATX101 Data - Analyst Blog

    February 05, 2013
    Bayer AG (BAYRY) recently presented results from two European phase III studies on ATX-101. ATX-101 is being ...
  20. SHPG Reaches Agreement with US Govt - Analyst Blog

    February 05, 2013
    Ireland-based Shire plc (SHPG) recently announced that the company has reached an agreement in principle to resolve ...
Marketplace
Trading Center